From innovative treatments to unequal access to medicine, I cover health topics and keep an eye on Switzerland's Health Valley.
I'm Swiss-Turkish, and have a background in communications, journalism and photography. Before joining SWI swissinfo.ch, I covered technology and health at Euronews, and my work has been featured in international outlets including Fayn Press, Mediapart, Le Temps and Times of Malta.
Swiss drugmakers face mixed fortunes amid Trump’s tariff upheaval
This content was published on
Pharma giants may escape the worst of the import tariffs threatened by the US. But Switzerland’s smaller developers face a more uncertain future.
When diagnosing a disease does more harm than good
This content was published on
Switzerland has the highest number of MRI scanners per person in Europe. But more screening doesn’t always lead to better health outcomes.
Potential US tariff exemption for Swiss pharma is not necessarily a boon
This content was published on
Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.
Rare diseases take centre stage at global health summit
This content was published on
Rare diseases have been recognised as a global health priority for the first time. How could this impact access to life-saving treatment?
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
Switzerland is home to Europe’s only psychedelics treatment
This content was published on
Doctors at Swiss hospitals and private practices are turning to alternative methods such as psychedelics. But the therapies are costly, rare and sometimes informal.
Electric touch: neurostimulation’s comeback in psychiatry
This content was published on
Faced with a lack of breakthroughs in treating mental health disorders, older methods such as electrical-based therapies are experiencing a revival.
From Jung to psychedelics: a timeline of Switzerland’s contributions to psychiatry
This content was published on
From the synthesisation of LSD to the commercialisation of antidepressants, Switzerland has played a key role in the understanding and treatment of psychiatry.
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
